These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 14513085

  • 1. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
    Harrison-Woolrych M, Zhou L, Coulter D.
    N Z Med J; 2003 Aug 08; 116(1179):U538. PubMed ID: 14513085
    [Abstract] [Full Text] [Related]

  • 2. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun 08; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 3. Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena).
    Zhou L, Harrison-Woolrych M, Coulter DM.
    Pharmacoepidemiol Drug Saf; 2003 Jun 08; 12(5):371-7. PubMed ID: 12899110
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH, Sayed GH, Hussien MM, Shaaban MM.
    Contraception; 2005 Nov 08; 72(5):346-51. PubMed ID: 16246660
    [Abstract] [Full Text] [Related]

  • 5. Hair loss with use of the levonorgestrel intrauterine device.
    Paterson H, Clifton J, Miller D, Ashton J, Harrison-Woolrych M.
    Contraception; 2007 Oct 08; 76(4):306-9. PubMed ID: 17900442
    [Abstract] [Full Text] [Related]

  • 6. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun 08; 18(101):125-30. PubMed ID: 19637436
    [Abstract] [Full Text] [Related]

  • 7. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA, Veldhuis HM, Lagro-Janssen TL.
    Contraception; 2004 Apr 08; 69(4):283-7. PubMed ID: 15033402
    [Abstract] [Full Text] [Related]

  • 8. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D, Janssens D, Vrijens M, Weyers S.
    Contraception; 2005 Jun 08; 71(6):465-9. PubMed ID: 15914138
    [Abstract] [Full Text] [Related]

  • 9. Ease of intrauterine contraceptive device insertion in family planning settings.
    Harvey C, Bateson D, Wattimena J, Black KI.
    Aust N Z J Obstet Gynaecol; 2012 Dec 08; 52(6):534-9. PubMed ID: 23106201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
    van Vliet HA, Tchaikovski SN, Rosendaal FR, Rosing J, Helmerhorst FM.
    Thromb Haemost; 2009 Apr 08; 101(4):691-5. PubMed ID: 19350113
    [Abstract] [Full Text] [Related]

  • 12. Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women.
    Harrison-Woolrych M, Ashton J, Coulter D.
    Contraception; 2002 Dec 08; 66(6):387-91. PubMed ID: 12499029
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levonorgestrel intrauterine device: new preparation. An alternative.
    Prescrire Int; 1999 Dec 08; 8(44):175-7. PubMed ID: 11503815
    [Abstract] [Full Text] [Related]

  • 15. Mirena at caesarean section.
    Puzey M.
    Eur J Contracept Reprod Health Care; 2005 Sep 08; 10(3):164-7. PubMed ID: 16318963
    [Abstract] [Full Text] [Related]

  • 16. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R, Knight I, Keane F.
    Int J STD AIDS; 2009 Jun 08; 20(6):423-4. PubMed ID: 19451330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D, Janssens D, Andrade A.
    Eur J Contracept Reprod Health Care; 2009 Apr 08; 14(2):103-10. PubMed ID: 19340705
    [Abstract] [Full Text] [Related]

  • 19. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
    Ng YW, Liang S, Singh K.
    Contraception; 2009 Jan 08; 79(1):24-8. PubMed ID: 19041437
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous breakage and expulsion of a stem fragment of levonorgestrel intrauterine system (Mirena) following duplicate insertion.
    Jindal S, Sharma SS, Ikomi A.
    Arch Gynecol Obstet; 2009 Jan 08; 279(1):95-7. PubMed ID: 18949478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.